Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today announced that it will present two posters at the American ...

Germ cell brain tumors are rare brain tumors that account for 2–3% of all primary intracranial tumors. They develop in the pineal or suprasellar region of the brain. These tumors can spread to ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival ...

This triple therapy slowed tumor growth and extended survival in a mouse model of glioblastoma, offering a potential new strategy for one of the most aggressive and treatment-resistant brain cancers.

Hubble AV seamlessly combines 4K visualization with lighting and graded suction into a single disposable device for rapid plug-and-play use for intracranial hematomas and tumors. Hubble AV ...